| LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins B Schorch, S Song, FR Van Diemen, HH Bock, P May, J Herz, ... Proceedings of the National Academy of Sciences 111 (17), 6431-6436, 2014 | 95 | 2014 |
| Cell-free synthesis and characterization of a novel cytotoxic pierisin-like protein from the cabbage butterfly Pieris rapae JHC Orth, B Schorch, S Boundy, R Ffrench-Constant, S Kubick, K Aktories Toxicon 57 (2), 199-207, 2011 | 87 | 2011 |
| Interaction of the Clostridium difficile binary toxin CDT and its host cell receptor, lipolysis-stimulated lipoprotein receptor (LSR) S Hemmasi, BA Czulkies, B Schorch, A Veit, K Aktories, P Papatheodorou Journal of Biological Chemistry 290 (22), 14031-14044, 2015 | 50 | 2015 |
| Zn-alloy provides a novel platform for mechanically stable bioresorbable vascular stents C Hehrlein, B Schorch, N Kress, A Arab, C von Zur Mühlen, C Bode, ... PLoS One 14 (1), e0209111, 2019 | 41 | 2019 |
| Activation loop phosphorylation regulates B‐Raf in vivo and transformation by B‐Raf mutants M Köhler, M Röring, B Schorch, K Heilmann, N Stickel, GJ Fiala, ... The EMBO journal 35 (2), 143-161, 2016 | 33 | 2016 |
| The inflammasome and type-2 immunity in Clostridium difficile infection A Donlan, WA Petri Jr Clinics in colon and rectal surgery 33 (02), 067-072, 2020 | 16 | 2020 |
| Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP‐2 pathway P Papatheodorou, S Song, D López‐Ureña, A Witte, F Marques, GS Ost, ... The FASEB journal 33 (4), 4883-4892, 2019 | 16 | 2019 |
| Inverse control of Rab proteins by Yersinia ADP-ribosyltransferase and glycosyltransferase related to clostridial glucosylating toxins GS Ost, C Wirth, X Bogdanović, WC Kao, B Schorch, PJK Aktories, ... Science Advances 6 (11), eaaz2094, 2020 | 10 | 2020 |
| Targeting oncogenic Ras by the Clostridium perfringens toxin TpeL B Schorch, H Heni, NI Zahaf, T Brummer, M Mione, G Schmidt, ... Oncotarget 9 (23), 16489, 2018 | 10 | 2018 |
| Bioresorbable zinc stent with ultra-thin center struts attenuates stent jail in porcine femoral artery bifurcations C Hehrlein, B Schorch, J Haberstroh, C Bode, L Mey, H Schwarzbach, ... Minimally Invasive Therapy & Allied Technologies 31 (1), 72-79, 2022 | 8 | 2022 |
| Two novel clostridial glucosylating-like toxins expressed in a Yersinia spp S Ost, B Schorch, P Papatheodorou, C Schwan, Y Belyi, K Aktories NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 391, S56-S56, 2018 | | 2018 |
| Uptake and Usage of the Large Glycosylating Toxin TpeL B Schorch Albert-Ludwigs-Universität Freiburg, 2016 | | 2016 |
| Strategies to inactivate oncogenic Ras proteins in cancer cells via the Clostridium perfringens TpeL toxin B Schorch, H Heni, L Sundermann, P Papatheodorou, K Aktories NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 388, S80-S80, 2015 | | 2015 |
| Interplay between the Clostridium difficile binary toxin CDT and its host cell receptor LSR S Hemmasi, B Czulkies, B Schorch, K Aktories, P Papatheodorou NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 388, S78-S78, 2015 | | 2015 |
| Identification of the host receptor for Clostridium perfringens TpeL toxin indicates a two-receptor model of clostridial glycosylating toxins P Papatheodorou, B Schorch, S Song, K Aktories NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 387, S16-S16, 2014 | | 2014 |
| Clostridium perfringens TpeL toxin as a tool to inactivate oncogenic Ras proteins B Schorch, P Papatheodorou, S Hornei, L Sundermann, G Guttenberg, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 386, S73-S73, 2013 | | 2013 |
